Early clinical management of autosomal recessive polycystic kidney disease
- PMID: 33594464
- PMCID: PMC8497312
- DOI: 10.1007/s00467-021-04970-8
Early clinical management of autosomal recessive polycystic kidney disease
Abstract
Autosomal recessive polycystic kidney disease (ARPKD) is a rare but highly relevant disorder in pediatric nephrology. This genetic disease is mainly caused by variants in the PKHD1 gene and is characterized by fibrocystic hepatorenal phenotypes with major clinical variability. ARPKD frequently presents perinatally, and the management of perinatal and early disease symptoms may be challenging. This review discusses aspects of early manifestations in ARPKD and its clincial management with a special focus on kidney disease.
Keywords: Ciliopathies; Congenital hepatic fibrosis; Fibrocystin; PKHD1; Perinatal kidney disease; Polycystic kidney disease.
© 2021. The Author(s).
Conflict of interest statement
As a representative of the University Hospital of Cologne, MCL serves on an advisory board of Otsuka Pharmaceuticals.
Figures
References
-
- Sweeney WE, Avner ED. Polycystic kidney disease, autosomal recessive. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Stephens K, Amemiya A, editors. GeneReviews®. Seattle, Seattle (WA): University of Washington; 1993.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
